Interleukin-12 is associated with arterial stiffness in healthy individuals

American Journal of Hypertension

Volumn 26, Issue 2, 2013, Pages 159-162

  Yong, Kenneth ^a,b   Dogra, Gursharan ^a   Boudville, Neil ^a,b   Chan, Doris ^a,b   Adams, Leon ^a,b   Ching, Helena ^a   Lim, Ee M ^a   Lim, Wai H ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

arterial stiffness; atherosclerosis; blood pressure; hypertension; inflammation; interleukin 12; interleukin 18

Indexed keywords

HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 12; INTERLEUKIN 18;

ADULT; ARTERIAL STIFFNESS; ARTICLE; AUGMENTATION INDEX; BODY MASS; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-18; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84876525255     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hps032     Document Type: Article

References (20)

1. Hansson GK, Libby P. The immune response in atherosclerosis: a doubleedged sword. Nat Rev Immunol 2006;6:508-519. (Pubitemid 43980523)
2. Davenport P, Tipping PG. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Pathol 2003;163:1117-1125. (Pubitemid 37040147)
3. Mallat Z, Corbaz A, Scoazec A, Besnard S, Leseche G, Chvatchko Y, Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598-1603. (Pubitemid 32947520)
4. Troseid M, Seljeflot I, Hjerkinn EM, Arnesen H. Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia. Diabetes Care 2009;32:486-492.
5. Mishra M, Kumar H, Bajpai S, Singh RK, Tripathi K. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes. Diabetes Res Clin Pract 2011;94:255-261.
6. Wong CK, Ho CY, Li EK, Tam LS, Lam CW. Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus. Clin Exp Immunol 2002;130:345-351. (Pubitemid 35286225)
7. Barnes JN, Nualnim N, Sugawara J, Sommerlad SM, Renzi CP, Tanaka H. Arterial stiffening, wave reflection, and inflammation in habitually exercising systemic lupus erythematosus patients. Am J Hypertens 2011;24:1194-1200.
8. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H; on behalf of the European Network for Non-Invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27: 2588-2605. (Pubitemid 44627304)
9. Blankenberg S, Luc G, Ducimetiere P, Arveiler D, Ferrieres J, Amouyel P, Amouyel P, Evans A, Cambien F, Tiret L. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003;108:2453-2459. (Pubitemid 37444405)
10. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ and for the AtheroGene Investigators. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24-30. (Pubitemid 34747437)
11. Vlachopoulos C, Ioakeimidis N, Aznaouridis K, Bratsas A, Baou K, Xaplanteris P, Lazaros G, Stefanadis C. Association of interleukin-18 levels with global arterial function and early structural changes in men without cardiovascular disease. Am J Hypertens 2010;23:351-357.
12. Harvey EJ, Ramji DP. Interferon-gamma and atherosclerosis: pro-or anti-atherogenic Cardiovasc Res 2005;67:11-20.
13. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002;195: 245-257. (Pubitemid 34461268)
14. Doring Y, Zernecke A. Plasmacytoid dendritic cells in atherosclerosis. Front Physiol 2012;3:230.
15. Ikonomidis I, Kadoglou N, Tsiotra PC, Kollias A, Palios I, Fountoulaki K, Halvatsiotis I, Maratou E, Dimitriadis G, Kremastinos DT, Lekakis J, Raptis SA. Arterial stiffness is associated with increased monocyte expression of adiponectin receptor mRNA and protein in patients with coronary artery disease. Am J Hypertens 2012;25:746-755.
16. Jung MY, Kim HS, Hong HJ, Youn BS, Kim TS. Adiponectin induces dendritic cell activation via PLCgamma/JNK/NF-kappaB pathways, leading to Th1 and Th17 polarization. J Immunol 2012;188: 2592-2601.
17. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H. Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 2002;17:1713-1724. (Pubitemid 35174279)
18. Giovannucci E. Vitamin D and cardiovascular disease. Curr Atheroscler Rep 2009;11:456-461.
19. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252-262. (Pubitemid 28058925)
20. Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D, Casteels KM, Laureys J, Bouillon R, Mathieu C. 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes 2000;49:1301-1307. (Pubitemid 30624229)